Youngone Corp Net Profit More Than Doubles in Q1 2026 on FX Windfall and OEM Rebound
Youngone Corp (111770.KS) net profit surged 113.2% YoY to KRW 149.7B in Q1 2026, driven by a KRW 58B FX translation windfall and strong OEM demand from The North Face, Lululemon and Patagonia.
KakaoBank to Acquire Masten Capital for KRW 24.1 Billion, Enters Capital-Finance Race With Auto Loan Ambitions
KakaoBank (323410.KS) will pay KRW 24.1 billion for a 100% stake in Masten Capital, marking its entry into Korea's auto and installment finance market by year-end 2026.
Korea's Presidential Chip Push: Samsung, SK Hynix to Sign KRW 300T Honam Cluster June 29 as Yongin Fast-Tracked a Decade
President Lee meets Samsung Chairman Lee Jae-yong June 25 to finalize KRW 300T+ Honam semiconductor cluster, signing set June 29-30 in Gwangju. Yongin mega-cluster pulled forward by a decade to 2034-35 alongside Samsung KRW 110T capex commitment.
Samsung and LG Race to Build the USD 176 Billion AI Modular Home Market
Samsung Electronics and LG Electronics are racing to dominate a USD 176 billion smart housing market by bundling AI, HVAC, and modular prefab homes — a pivot beyond traditional white goods.
KOSPI Eyes Historic 9,000 as SK Hynix Extends Market-Cap Crown on Micron Earnings Beat
South Korea's KOSPI surged 5.6% toward 9,000 on Thursday as SK Hynix jumped 11.6%, extending its new role as Korea's largest listed company after Micron's AI-driven earnings beat.
Samsung C&T Posts 7.5% Revenue Growth in Q1 2026, Net Income Jumps 15.9% on Bio Surge
Samsung C&T Q1 2026: Revenue KRW 10.47T (+7.5% YoY), OP KRW 720.4B (-0.6%), Net Income KRW 1.086T (+15.9%). Bio segment drove 67% of operating profit. Construction backlog KRW 92.4T.
Korea Unveils First-Ever 'Korea Rising' Session at BIO 2026 as Celltrion Bets on AI-Drug Pivot and ABL Bio Eyes Global Licensing
Korea debuts 'Korea Rising' session at BIO 2026 as Celltrion pivots to AI drugs and ABL Bio seeks global licensing deals, while KB Investment warns Korean biotechs to form US subsidiaries to access institutional capital.
Samsung Biologics CEO Reaffirms 15-20% Growth Target at BIO USA 2026, Advances Rockville Ramp and Netherlands Hub
Samsung Biologics CEO John Rim unveiled a three-pillar global expansion at BIO USA 2026: Rockville integration (USD 280M, 60,000L), Netherlands hub (Q3 2026), and Songdo Plant 6 decision by year-end, targeting 1.3 million liters by 2032.
Hanwha Aerospace Signs UAE Teaming Deal to Build K9 Howitzer Locally, Deepening Middle East Defense Footprint
South Korea's Hanwha Aerospace signed a teaming agreement with UAE's Generation 5 Holding at Eurosatory 2026 to produce the K9 self-propelled howitzer locally in the UAE, extending its Middle East defence footprint.
Samsung's Financial Affiliates Cross KRW 100 Trillion in Capital for First Time as Stock Rally Drives Unrealized Gains
Samsung Life, Samsung Fire, Samsung Card and Samsung Securities collectively surpassed KRW 100 trillion in capital for the first time at end-2025, with a KRW 31 trillion gain accounting for nearly thr
Korea's Big-Three Department Stores Each Poised to Cross KRW 1 Trillion in Foreign Sales as Tourism Hits 10 Million Ahead of Schedule
Hyundai Department Store, Shinsegae, and Lotte are each on track to surpass KRW 1 trillion in foreign-customer sales in 2026 as inbound tourism to Korea reached 10 million visitors ahead of schedule and K-wave demand drives luxury and fashion spending.
Samsung Electronics Weighs KRW 90 Trillion Buyback as Memory Export Boom Signals Q2 Earnings Beat
Samsung Electronics surged 9.84% after Yonhap reported a KRW 90 trillion (USD 59B) share buyback plan, while NAND export prices surged 822% YoY and Nomura raised its target price to KRW 670,000.